ATH alterity therapeutics limited

Ann: Webcast Today - New Data from bioMUSE Natural History Study, page-4

  1. 3,622 Posts.
    lightbulb Created with Sketch. 341
    Good presentation.

    Mid study point is now going to be released in July, 2 weeks after anticipated primary release date.

    Some good data coming through, they both, IMO, seem quite positive on the study and the use of ATH434.

    Some of the new data looks like it may be added to the end points of the study, to assist with FDA approval.

    Anyone else watch it ?.

    If so, thoughts ?.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.3¢
Change
-0.001(7.14%)
Mkt cap ! $119.6M
Open High Low Value Volume
1.3¢ 1.3¢ 1.2¢ $437.0K 33.88M

Buyers (Bids)

No. Vol. Price($)
35 9477809 1.2¢
 

Sellers (Offers)

Price($) Vol. No.
1.3¢ 3248157 9
View Market Depth
Last trade - 14.13pm 22/07/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.